Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays

Cytotherapy

Volumn 12, Issue 7, 2010, Pages 951-960

  Williams, Brent A ^a,b   Wang, Xing Hua ^a   Keating, Armand ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

chromium release assay; clonogeneic assay; flow cytometry; KG1; leukemic stem cell; NK 92

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTARABINE; DAUNORUBICIN; METHYLCELLULOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CHROMIUM 51 RELEASE; CLONOGENIC ASSAY; COLONY FORMATION; CYTOTOXICITY; FLOW CYTOMETRY; FRACTIONATION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 77957983164     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653241003628167     Document Type: Article

References (20)

1. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, et al. A cell initiating human myeloid leukemia after transplantation into SCID mice. Nature. 1994;367; 645-8.
2. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730-7.
3. Al Hajj M, Wicha MS, Benito-Hernandez A, Morrision SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003;100:3983-8.
4. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB. Cancer Res. 2003;63:5821-8.
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396-401.
6. Ricci-Vitiani L, Lobardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon cancer-initiating cells. Nature. 2007; 445:111-15.
7. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immuno-deficient mice. Nature. 2007;45:106-10.
8. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, et al. Characterization of clonogenic multiple myeloma cells. Blood. 2004;103:2332-6.
9. Kondo T, Setoguchi T, Taga T. Persistence of a small sub-population of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 2004;101:781-6.
10. Gong J, Maki G, Klingemann H-G. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells. Leukemia. 1994:8;652-8.
11. Yan Y, Steinherz P, Klingemann H-G, Dennig D, Childs BH, McGuirk J, et al. Antileukemia activity of a natural killer cell line against human leukemias. Clin Cancer Res. 1998;4: 2859-68.
12. Aria S, Meagher R, Swearingen M, Myint H, Rich E, Martinson J, Klingemann H. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase Itrial. Cytotherapy. 2008;10:625-32.
13. Costello RT, Mallet F, Gaugle B, Sainty D, Arnoulet C, Gastaut J-A, et al. Human acute myeloid leukaemia CD34+/ CD38-progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenic-ity, and impaired dendritic cell transformation capacities. Cancer Res. 2000;60:4403-11.
14. Jacobs P, Wood L. Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia. Hematology. 2005;10:321-6.
15. Curtis JE, Mnden MD, Minkin S, McCulloch EA. Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors. Leukemia. 1995;9:396-404.
16. Curtis DJ, Metcalf D, Alexander B, Begley CG. Leukemic cells from murine myeloid leukemia display an intrinsic ability for autonomous proliferation. Exp Hematol. 2000; 28:36-45.
17. Suck G, Branch DR, Smyth MJ, Miller RG, Vergidis J, Fahim S, Keating A. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity. Exp Hematol. 2005;33:1160-71.
18. Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood. 2008;112:568-75.
19. Brunner KT, Mauel J, Cerottini JC, Chapus B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by iso-antibodies and by drugs. Immunology. 1968;14:181-96.
20. Ozdemir O, Ravindranath Y, Savasan S. Cell-mediated cyto-toxicity evaluation using monoclonal antibody staining for target or effector cells with annexin V/propridium iodide colabeling by fl uorosphere-adjusted counts on three-color fl ow cytometery. Cytometry. 2003;56A;53-60.